OUR SCIENCEGensco® Pharma’s abilities provide boundless possibilities for improving health utilizing our unique preparations, innovative dosing methods, and proprietary drug delivery technologies.
Transdermal Technology Gensco® Pharma has developed and patented a unique transdermal drug delivery system... read more
MDose® Gensco® Pharma’s patented topical metered dose applicator dispenses an exact and consistent dose of medication with every pump... read more
PRODUCTSColciGel® Prepare for the flare with the first transdermal treatment for gout flares... read more
Astero® The first FDA-approved prescription combination drug-device hydrogel containing Lidocaine 4% HCl for associated pain, wound healing and vasculitis.... read more
LiDORx® Delivers fast controlled pain relief at the site... read more
SpeedGel Rx® Non-NSAID alternative for pain, inflammation and bruising. Targeting the source of pain... faster... read more
- January 25 - January 26
- January 26 @ 11:30 am - 11:59 pm EST
- February 11 - February 12
- February 12 - February 14
- February 16 - February 20
Looking To The Future
A single dose topical colchinium for acute gout flares.
A single dose topical anesthetic for injections and vaccines.
- A Case Study of Treatment of Recalcitrant Nonpressure Chronic Ulcers Using Astero Gel Topical Hydrogel with 4% Lidocaine for Autolytic Debridement and Pain Management November 13, 2017 Articles, Clinical, Featured, Research -
- An Exploratory, Single-blind Study to Evaluate Both the Onset of Anesthesia of LiDORx® in Patients Aged 18–88 Years November 9, 2017 Clinical, Research -
- Now Available Through Federal Supply Schedule (FSS) September 26, 2017 Featured, Press Release, Product Update - Contract #V797D-70219 The Only FDA-Approved Prescription Hydrogel and 4% Lidocaine HCl for Pain Associated with more...
- How to Best Navigate the Specialty Pharmacy Marketplace July 26, 2017 Industry, Press Release - Carlos Alfaras, President and CEO of Gensco Pharma, joins Suzette DiMascio, CHE, CMCE, CPC, host more...